James Wescott

James Wescott has extensive work experience in the pharmaceutical and biotechnology industry. James most recently served as the Senior Vice President of Project and Development Program Management at PTC Therapeutics, Inc. since May 2021. Prior to that, they held the role of President at Wescott BioPharma Services from July 2020 to May 2021. Additionally, James worked at Allergan as the Vice President of Project and Portfolio Management from December 2014 to July 2020. James also held leadership positions at POTENZA Therapeutics, Inc. and Wescott BioPharma Services. Earlier in their career, James worked at Merck, Schering-Plough Research Institute, ImClone Systems, and Rockefeller University in various senior positions.

James Wescott completed their Bachelor of Arts (B.A.) in Biochemistry from the University of Pennsylvania from 1983 to 1987. James'seducation history also includes pursuing an MBA in Finance from NYU Stern School of Business, although the specific start and end years are not provided.